Mesenchymal Stem Cells (MSC) Research

Mesenchymal Stem Cells (MSC) Therapy:
New Hope For Regenerative Medicine

Stem cell research has undergone 50 to 70 years of evolution. In the recent 10 years, medical research have brought in new hope to regenerative medicine through the application of Mesenchymal Stem Cells (MSC) in medical industry.

Due to specific factors, only few of the stem cell cultivation and manufacturing institute have obtained approval from relevant authority in certain countries. However, clinical researches on mesenchymal stem cells have been carried out in many countries, and its related technologies are becoming more mature. The MSC therapy is highly anticipated and widely recognized by the global medical community, and it is much anticipated that the MSC therapy will become the world’s mainstream regenerative therapy.

* Map remark:
Countries conducting umbilical cord blood Mesenchymal Stem Cell research.

According to the clinical research data presented by National Institutes of Health, USA (NIH), more than 376 cases of clinical trials have been proven with the safety and efficiency of Umbilical Cord Blood Mesenchymal Stem Cell (MSC).

Located in Bethesda, Maryland, USA, NIH is the highest-level medical and behavioral research institution in the United States. It was founded in 1887 to explore the essence of life and behavior.

And make full use of this knowledge to extend human life, as well as prevent, diagnose and treat various diseases and disabilities. The research results obtained by NIH in recent decades have greatly improved the health of human beings.

Copyright by Cell Life 2019. All rights reserved.